Verenium Stock Price, News & Analysis (NASDAQ:VRNM)

$3.99 0.00 (0.00 %)
(As of 12/15/2017 12:40 PM ET)
Previous Close$3.99
Today's RangeN/A
52-Week Range$2.00 - $4.00
VolumeN/A
Average Volume240,414 shs
Market Capitalization$51.01 million
P/E RatioN/A
Dividend YieldN/A
Beta0.83

About Verenium (NASDAQ:VRNM)

Verenium logoVerenium Corporation (Verenium) is an industrial biotechnology company. The Company develops and commercializes enzymes for use in a range of industrial processes. It manufactures and markets its enzyme products in the fields of animal health and nutrition, grain processing, oilfield services and other industrial processes, such as pulp and paper and textiles. As of December 31, 2012, it marketed commercial enzyme products, either independently or in collaboration with its partners. In addition, it has developed a pipeline of enzyme product candidates. Its products are organized into four product lines: animal health and nutrition, grain processing, oilfield services and other industrial processes. As of December 31, 2012, it markets nine commercial enzyme products. In October 2013, BASF SE acquired 71% stake in the Company.

Receive VRNM News and Ratings via Email

Sign-up to receive the latest news and ratings for VRNM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Commodity Chemicals
Sub-IndustryN/A
SectorBasic Materials
SymbolNASDAQ:VRNM
CUSIPN/A
WebN/A
Phone+1-858-4318500

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A

Verenium (NASDAQ:VRNM) Frequently Asked Questions

What is Verenium's stock symbol?

Verenium trades on the NASDAQ under the ticker symbol "VRNM."

Who are some of Verenium's key competitors?

Who are Verenium's key executives?

Verenium's management team includes the folowing people:

  • James H. Cavanaugh Ph.D., Independent Chairman of the Board (Age 77)
  • James E. Levine, President, Chief Executive Officer, Director (Age 43)
  • Jeffrey G. Black, Chief Financial Officer, Senior Vice President (Age 48)
  • Janet S. Roemer, Chief Operating Officer, Executive Vice President - Specialty Enzymes Business Unit (Age 57)
  • Alexander A. Fitzpatrick, Senior Vice President, General Counsel, Secretary (Age 47)
  • John F. Dee, Independent Director (Age 56)
  • Peter R Johnson, Independent Director (Age 61)
  • Fernand J. Kaufmann, Independent Director (Age 70)
  • Holger A. Liepmann, Independent Director (Age 63)
  • Joshua Ruch, Independent Director

How do I buy Verenium stock?

Shares of Verenium can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Verenium's stock price today?

One share of Verenium stock can currently be purchased for approximately $3.99.

How big of a company is Verenium?

Verenium has a market capitalization of $51.01 million.

How can I contact Verenium?

Verenium's mailing address is 3550 John Hopkins Ct, SAN DIEGO, CA 92121-1121, United States. The biotechnology company can be reached via phone at +1-858-4318500.


MarketBeat Community Rating for Verenium (VRNM)

Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  28 (Vote Outperform)
Underperform Votes:  45 (Vote Underperform)
Total Votes:  73
MarketBeat's community ratings are surveys of what our community members think about Verenium and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Verenium (NASDAQ:VRNM) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Verenium (NASDAQ:VRNM) Earnings History and Estimates Chart

Earnings by Quarter for Verenium (NASDAQ:VRNM)

Verenium (NASDAQ VRNM) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/7/2013Q2 2013($0.32)($0.36)$15.70 million$15.39 millionViewN/AView Earnings Details
3/27/2013Q4 2012($0.29)($0.28)$14.32 million$13.98 millionViewN/AView Earnings Details
11/8/2012Q312($0.41)$18.42 million$10.26 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Verenium (NASDAQ:VRNM) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Verenium (NASDAQ:VRNM)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Verenium (NASDAQ VRNM) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for Verenium (NASDAQ:VRNM)

Verenium (NASDAQ VRNM) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/18/2013Austin & Greenhouse Da Marxemajor shareholderSell8,100$2.94$23,814.00View SEC Filing  
9/13/2013Austin & Greenhouse Da Marxemajor shareholderSell8,564$2.90$24,835.60View SEC Filing  
9/5/2013Austin W & Greenhouse Da MarxeMajor ShareholderSell10,595$2.74$29,030.30View SEC Filing  
8/7/2013Austin & Greenhouse Da Marxemajor shareholderSell14,200$3.14$44,588.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Verenium (NASDAQ VRNM) News Headlines

Source:
DateHeadline
Head to Head Survey: Verenium (VRNM) and Its RivalsHead to Head Survey: Verenium (VRNM) and Its Rivals
www.americanbankingnews.com - December 7 at 9:24 AM
Verenium (VRNM) and The Competition Head to Head ReviewVerenium (VRNM) and The Competition Head to Head Review
www.americanbankingnews.com - December 5 at 5:26 PM
Contrasting Enzymotec (ENZY) and Verenium (VRNM)Contrasting Enzymotec (ENZY) and Verenium (VRNM)
www.americanbankingnews.com - December 2 at 7:18 PM
Comparing CSW Industrials (CSWI) and Verenium (VRNM)Comparing CSW Industrials (CSWI) and Verenium (VRNM)
www.americanbankingnews.com - December 2 at 1:38 PM
Financial Analysis: Verenium (VRNM) and Its CompetitorsFinancial Analysis: Verenium (VRNM) and Its Competitors
www.americanbankingnews.com - November 30 at 1:28 AM
Reviewing Verenium (VRNM) & Its PeersReviewing Verenium (VRNM) & Its Peers
www.americanbankingnews.com - November 26 at 11:20 AM
Head-To-Head Review: Verenium Corp (VRNM) & Its RivalsHead-To-Head Review: Verenium Corp (VRNM) & Its Rivals
www.americanbankingnews.com - November 25 at 3:26 AM
Comparing Verenium Corp (VRNM) & Its PeersComparing Verenium Corp (VRNM) & Its Peers
www.americanbankingnews.com - November 24 at 11:16 PM
Head-To-Head Survey: Verenium Corp (VRNM) and Quaker Chemical Corporation (KWR)Head-To-Head Survey: Verenium Corp (VRNM) and Quaker Chemical Corporation (KWR)
www.americanbankingnews.com - November 19 at 3:28 PM
Contrasting Verenium Corp (VRNM) & Its RivalsContrasting Verenium Corp (VRNM) & Its Rivals
www.americanbankingnews.com - November 18 at 7:24 PM
Contrasting Enzymotec (ENZY) & Verenium Corp (VRNM)Contrasting Enzymotec (ENZY) & Verenium Corp (VRNM)
www.americanbankingnews.com - November 18 at 8:48 AM
Head to Head Review: Verenium Corp (VRNM) & Its RivalsHead to Head Review: Verenium Corp (VRNM) & Its Rivals
www.americanbankingnews.com - November 8 at 2:08 PM

SEC Filings

Verenium (NASDAQ:VRNM) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Verenium (NASDAQ:VRNM) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Verenium (NASDAQ VRNM) Stock Chart for Friday, December, 15, 2017

Loading chart…

This page was last updated on 12/15/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.